U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
UCB-0107
Preferred Name English
BEPRANEMAB
INN   USAN  
Official Name English
bepranemab [INN]
Common Name English
RECOMBINANT HUMANISED IgG4P KAPPA LIGHT CHAIN GAMMA HEAVY CHAIN ANTI-TAU MONOCLONAL ANTIBODY UCB0107
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE ASSOCIATED PROTEIN TAU, TAU)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV4-4*08 (83.5%)-(IGHD)- IGHJ3*01 (93.3%)) CDR-IMGT (8.7.12) (26-33.51-57
Common Name English
BEPRANEMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN TAU PROTEIN) (HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB0107 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB0107 .KAPPA.-CHAIN, DIMER
Common Name English
UCB0107
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 598117
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
Code System Code Type Description
FDA UNII
9M1GV6L389
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
CLINICAL_TRIALS.GOV
NCT03464227
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
SMS_ID
300000001080
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
NCI_THESAURUS
C174583
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
USAN
JK-171
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
CAS
2244960-75-4
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
CLINICAL_TRIALS.GOV
NCT04185415
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
INN
11224
Created by admin on Wed Apr 02 06:15:41 GMT 2025 , Edited by admin on Wed Apr 02 06:15:41 GMT 2025
PRIMARY
ACTIVE MOIETY
BEPRANEMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966